The stock has experienced a severe downtrend over the past six months, declining 36.59% from its price in early October 2025. The current price of $432.38 is near the lower end of its 52-week range of $349 to $813.7, representing a significant drawdown from its high. Short-term performance shows a 5.71% gain over the past month, which is a positive relative strength of 10.96% compared to the S&P 500's 5.25% decline, indicating a potential near-term stabilization after the sharp sell-off. The stock's current position is precarious, trading approximately 47% below its 52-week high and only 24% above its 52-week low, reflecting substantial bearish pressure and investor concerns over the recent period.

Revenue in the latest quarter (Q2 2026) was $4.65 billion, showing strong year-over-year growth of 17.36%. Profitability has improved sequentially, with net income rising from $446 million in Q1 to $693 million in Q2, and the net margin expanding from 11.5% to 14.9%. Financial health appears stable with a manageable debt-to-equity ratio of 0.34 and robust trailing twelve-month free cash flow of $6.84 billion, providing ample liquidity. Operational efficiency is solid, as evidenced by a return on equity (ROE) of 19.63% and a return on assets (ROA) of 10.33%, indicating effective use of shareholder capital and company assets.